BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19039943)

  • 1. Cells of rhabdomyosarcoma PA-23 tumor clones with high and low metastatic potential differ by activity of lysosomal sialidase.
    Proshin SN; Kaminskaya EV; Lebedev AA; Shabanov PD
    Bull Exp Biol Med; 2008 Mar; 145(3):355-7. PubMed ID: 19039943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploinsufficiency of the lysosomal sialidase NEU1 results in a model of pleomorphic rhabdomyosarcoma in mice.
    Machado ER; van de Vlekkert D; Sheppard HS; Perry S; Downing SM; Laxton J; Ashmun R; Finkelstein DB; Neale GA; Hu H; Harwood FC; Koo SC; Grosveld GC; d'Azzo A
    Commun Biol; 2022 Sep; 5(1):992. PubMed ID: 36127469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic potential of transformed rat 3Y1 cell lines is inversely correlated with lysosomal-type sialidase activity.
    Miyagi T; Sato K; Hata K; Taniguchi S
    FEBS Lett; 1994 Aug; 349(2):255-9. PubMed ID: 8050577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective myogenic differentiation of human rhabdomyosarcoma cells is characterized by sialidase Neu2 loss of expression.
    Stoppani E; Rossi S; Marchesini S; Preti A; Fanzani A
    Cell Biol Int; 2009 Sep; 33(9):1020-5. PubMed ID: 19524683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of lysosomal-type sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells.
    Kato T; Wang Y; Yamaguchi K; Milner CM; Shineha R; Satomi S; Miyagi T
    Int J Cancer; 2001 Jun; 92(6):797-804. PubMed ID: 11351298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of lysosomal ganglioside sialidase in human cells.
    Zeigler M; Sury V; Bach G
    Eur J Biochem; 1989 Aug; 183(2):455-8. PubMed ID: 2759093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Removal of surface antigens and changes in metastatic potential of transplantable rat rhabdomyosarcoma RA-2 cells].
    Guzhova IV; Margulis BA
    Eksp Onkol; 1988; 10(5):31-2. PubMed ID: 3208686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence in brain lysosomes of a sialidase active on ganglioside.
    Fiorilli A; Venerando B; Siniscalco C; Monti E; Bresciani R; Caimi L; Preti A; Tettamanti G
    J Neurochem; 1989 Sep; 53(3):672-80. PubMed ID: 2760615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
    Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
    Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation.
    Vinogradova MV; Michaud L; Mezentsev AV; Lukong KE; El-Alfy M; Morales CR; Potier M; Pshezhetsky AV
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):641-50. PubMed ID: 9480870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal localization of Japanese medaka (Oryzias latipes) Neu1 sialidase and its highly conserved enzymatic profiles with human.
    Ryuzono S; Takase R; Oishi K; Ikeda A; Chigwechokha PK; Funahashi A; Komatsu M; Miyagi T; Shiozaki K
    Gene; 2016 Jan; 575(2 Pt 2):513-523. PubMed ID: 26432003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal and cytosolic sialidases in rabbit alveolar macrophages: demonstration of increased lysosomal activity after in vivo activation with bacillus Calmette-Guerin.
    Pilatte Y; Bignon J; Lambré CR
    Biochim Biophys Acta; 1987 Jan; 923(1):150-5. PubMed ID: 3542051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal cathepsin B: correlation with metastatic potential.
    Sloane BF; Dunn JR; Honn KV
    Science; 1981 Jun; 212(4499):1151-3. PubMed ID: 7233209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialidase of rat hepatomas: qualitative and quantitative comparison with rat liver sialidase.
    Miyagi T; Goto T; Tsuiki S
    Gan; 1984 Dec; 75(12):1076-82. PubMed ID: 6526222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on kidney sialidase in normal and diabetic rats.
    Cohen-Forterre L; Mozere G; Andre J; Sternberg M
    Biochim Biophys Acta; 1984 Sep; 801(1):138-45. PubMed ID: 6466710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of gangliosides by the lysosomal sialidase requires an activator protein.
    Fingerhut R; van der Horst GT; Verheijen FW; Conzelmann E
    Eur J Biochem; 1992 Sep; 208(3):623-9. PubMed ID: 1396669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of cancer metastasis].
    Poupon MF; Becker M; Pauwels C; Moczar E; Korach S
    Bull Cancer; 1984; 71(5):453-63. PubMed ID: 6395921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecto-ganglioside-sialidase activity of herpes simplex virus-transformed hamster embryo fibroblasts.
    Schengrund CL; Rosenberg A; Repman MA
    J Cell Biol; 1976 Sep; 70(3):555-61. PubMed ID: 182699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and and some properties.
    Lieser M; Harms E; Kern H; Bach G; Cantz M
    Biochem J; 1989 May; 260(1):69-74. PubMed ID: 2775195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of plasma membrane ganglioside sialidase of human neuroblastoma cells in growth control and differentiation.
    Kopitz J; von Reitzenstein C; Mühl C; Cantz M
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1188-93. PubMed ID: 8147859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.